About Parnax Lab Limited

Parnax Lab Limited is an Indian pharmaceutical company headquartered at Gala 114, Building No. 8, Jogani Industrial Complex, Chunabhatti, Mumbai – 400022, with equity shares listed on BSE Limited (stock code 506128)  . The company is engaged in pharmaceuticals and medicinal products, with a distinct niche in the veterinary markets. Its focus is on developing markets in the rest of the world rather than the developed markets of America, Europe and Japan . Parnax maintains “Works” at Masat Industrial Estate, Silvassa, Dadra & Nagar Haveli, indicating an operational footprint beyond its registered office in Mumbai.

As on March 31, 2025, the company had 1 subsidiary (consolidated into group accounts) . Parnax’s equity is listed only on BSE, and the Corporate Identification Number (CIN) is L36912MH1982PLC027925. The company’s history includes a prior name, Krishna Deep Trade & Investment Ltd., as reflected in the company’s correspondence header.

Parnax Lab Limited Milestones 

Key milestones include the conversion of warrants by promoters on July 1, 2022, which increased paid-up share capital to Rs 11,48,56,160 (1,14,85,616 equity shares of face value Rs 10 each) and lifted the securities premium reserve to Rs 9,98,55,125. Earlier, on March 30, 2022, a prior tranche of warrant conversion had also taken place; cumulatively, these issues were utilised for the objects of the preferential issue . The share capital note further records that 53,04,866 shares were issued at the time of a scheme of amalgamation (historical detail noted in the capital structure).

Parnax Lab Limited Key Management

• Mihir P. Shah – Managing Director & CEO (appointed w.e.f. November 14, 2024)
• Binoy B. Shah – Director & CFO (appointed w.e.f. November 14, 2024)
• Preet Kukreja – Company Secretary & Compliance Officer

Latest Updates on Parnax Lab Limited

• Leadership changes: Mr. Prakash M. Shah (Director & CEO) and Mr. Baiju M. Shah (Managing Director & CFO) resigned w.e.f. July 5, 2024; Mr. Mihir P. Shah and Mr. Binoy B. Shah were appointed as Managing Director & CEO and Director & CFO, respectively, w.e.f. November 14, 2024.
• Board composition: Mr. Vijay Kumar Ayare joined as Independent and Non-Executive Director w.e.f. March 21, 2025; Mr. Tirunillai V. Anantharaman retired w.e.f. March 30, 2025  .
• AGM and governance: The 43rd AGM is scheduled for September 29, 2025 at 12:30 p.m. via VC/OAVM. Ordinary business includes adoption of accounts for the year ended March 31, 2025 and re-appointment of a director retiring by rotation .
• Shareholders’ approvals: At the AGM held on September 27, 2024, shareholders approved sale and purchase of material with the subsidiary up to Rs 5 crore for each category of transaction.
• Financial reporting: The Board approved the consolidated financial statements for issue on May 27, 2025; the CEO/CFO certification to the Board is dated August 13, 2025.
• Subsidiary-related update: In the Board meeting held on March 28, 2025, subject to member approval, the company recommended revised remuneration limits for certain whole-time directors of the subsidiary effective April 1, 2025; shareholders approved these on March 31, 2025.